Associated factors of DRPs. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Association of independent variable with DRPs. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Lifestyle-Related characteristics of patients. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Drug-Related problems identified. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Socio-Demographic characteristics of patients. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Minimal data set. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Drugs class and drugs responsible for DRPs. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Comparison of VD and PA in the five groups of DVC. by Jin Jiang (188887)

Subjects:

Comparison of parameter indicators among groups. by Jin Jiang (188887)

Subjects:

Comparison of superficial and deep capillary plexus flow density among various groups. by Jin Jiang (188887)

Subjects:

Heterogeneity test results. by Xi Ji (7015277)

Subjects:

Methodological Summary: Data Collection and Analytic Plan. by Reuben Ng (692015)

Subjects:

Ologit regression results. by Xi Ji (7015277)

Subjects:

Contrast of general data of various groups. by Jin Jiang (188887)

Subjects:

Prominent Peaks of Israel-Hamas Conflict (2023) across 1 billion online posts. by Reuben Ng (692015)

Subjects:

Comparison of VD, PA and SVD in different groups of SVC. by Jin Jiang (188887)

Subjects:

Comparison of optic disc parameters among groups. by Jin Jiang (188887)

Subjects:

Flowchart of study participants. by Jin Jiang (188887)

Subjects:

Data. by Jin Jiang (188887)

Subjects:

Comparison of retinal thickness among different groups. by Jin Jiang (188887)

Subjects: